The Drug Delivery to the Lungs Conference (DDL) is in it’s 34th year and attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event.  DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.